Kouichi Sakaguchi

Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer

Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Oouchi et al. · Breast Cancer · 2016 · 48 citations

Medicine, Oncology, Pharmacology +14

Effect of denosumab administration on low bone mineral density (T-score −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer

Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Ouchi et al. · Journal of Bone and Mineral Metabolism · 2017 · 19 citations

Medicine, Oncology, Pharmacology +17

Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer

Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Ouchi et al. · Journal of Bone and Mineral Metabolism · 2018 · 19 citations

Medicine, Oncology, Pharmacology +17

Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results

Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Ouchi et al. · Breast Cancer · 2018 · 14 citations

Medicine, Oncology, Pharmacology +17

Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer

Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Oouchi et al. · Breast Cancer · 2016 · 12 citations

Medicine, Oncology, Pharmacology +14